This article has been retracted: Aging has completed its investigation of this paper. Multiple concerns were raised about this paper, including overlap with unrelated papers from different institutions. We found overlap between the transwell images in Figures 5C and 6E and images from an earlier published unrelated paper [1]. We also found that the tumor images in Figure 7B were previously published in an unrelated paper from a different lab [2]. In addition, the same distinctively scratched ruler was used to measure xenograft tumors in a number of other papers from unrelated teams of authors [2, 3, 4]. The formats of the selected papers [3, 4] are nearly identical, with some figures being almost indistinguishable. Aging Scientific Integrity office contacted the authors but the authors did not respond to requests to clarify and the paper was retracted based on Editorial decision. The Scientific Integrity office also notified authors’ Institutions about this retraction and added their names to the Editorial Warning list.

References

  • 1. Li S, Liu F, Pei Y, Wang W, Zheng K, Zhang X. Long noncoding RNA TTN-AS1 enhances the malignant characteristics of osteosarcoma by acting as a competing endogenous RNA on microRNA-376a thereby upregulating dickkopf-1. Aging (Albany NY). 2019; 11:7678–93. https://doi.org/10.18632/aging.102280 [PubMed]
  • 2. Zhang S, Long J, Hu Y. Long noncoding RNA LINC00205 enhances the malignant characteristics of retinoblastoma by acting as a molecular sponge of microRNA-665 and consequently increasing HMGB1 expression. Biochem Biophys Res Commun. 2020; 526:396–403. https://doi.org/10.1016/j.bbrc.2020.03.083 [PubMed]
  • 3. Yu D, Xu X, Li S, Zhang K. LINC00514 drives osteosarcoma progression through sponging microRNA-708 and consequently increases URGCP expression. Aging (Albany NY). 2020; 12:6793–807. https://doi.org/10.18632/aging.103043 [PubMed]
  • 4. Yang F, Lei P, Zeng W, Gao J, Wu N. Long Noncoding RNA LINC00173 Promotes the Malignancy of Melanoma by Promoting the Expression of IRS4 Through Competitive Binding to microRNA-493. Cancer Manag Res. 2020; 12:3131–44. https://doi.org/10.2147/CMAR.S243869 [PubMed]. Retraction in: Cancer Manag Res. 2021; 13:7507–8. https://doi.org/10.2147/CMAR.S341519 [PubMed]